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Abstract. The essential role of tyrosine residue(s) of cardiotoxin II in the biological activity 
of the toxin was evaluated using N-bromosuccinimide. N-bromosuccinimide effected oxida- 
tion of the tyrosine residues in cardiotoxin II with enhancement in absorbance at 260 nm. 
The influence of various solvent media such as acetate-formate buffer (pH 4·0),0·01 Ν 
H2SO4 (pH 2·0) and Tris-HCl buffer (pH 8·5) on oxidation of tyrosine residues was exa 
mined. In comparison with 0·01 Ν H2S O4, acetate-formate buffer could prevent secondary 
oxidations as revealed by lower consumption of oxidant, N-bromosuccinimide, to achieve 
oxidation. In Tris-HCl buffer oxidation of tyrosine did not take place effectively. N-iodo-
succinimide caused only limited oxidation as evident from minor increase in absorbance at 
260 nm. N-chlorosuccinimide was completely ineffective. Oxidation of cardiotoxin II with 
3·75 equivalents of N-bromosuccinimide tyrosine residue led to complete loss of lethal acti- 
vity. However, the derivative retained the ability to protect bacterial protoplasts from 
lysis in solutions of low tonicity. Unlike cardiotoxin II oxidized with N-chlorosuccinimide 
(50 equivalents/mol of toxin) which retained lethal activity as well as the ability to protect 
protoplasts from lysis, performic acid-oxidized toxin had lost both the activities. 
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Introduction 
 
Cardiotoxins are non-neurotoxic protein constituents of cobra venom. These basic 
toxins are known for their membrane destabilizing property (Condrea, 1974). 
Recently we have shown that cardiotoxin II stabilizes bacterial protoplasts against 
lysis under hypotonic condition (Shashidharan and Ramachandran, 1984). 
Chemical modification studies on biologically active proteins are carried out in 
delineating amino acid side chains which are important for their structure and 
function. An earlier report of ours had dealt with the side-chain amino groups of 
cardiotoxin II for biological activity (Shashidharan and Ramachandran, 1985). In 
this paper observations on modification of tyrosine residues with N-bromosuccini- 
mide (NBS) are reported. Earlier reports (Keung et al., 1975; Carlsson, 1980) of 
modifications of tyrosine sidechains in cardiotoxins had been achieved using tetra-
nitromethane (TNM). Cardiotoxin II is eminently suited for oxidative modification 
studies with NBS, because the toxin contains neither tryptophan nor histidine 
(Srinivasa et al., 1982) whose side chains also are known to be susceptible to modifica 
tion by the reagent (Witkop, 1961). The usefulness of other oxidizing agents such as N-
chlorosuccinimide (NCS) and N-iodosuccinimide (NIS) in effecting oxidation of 
tyrosine residues has also been examined. 
 
 
† To whom all correspondence should be addressed. 
Abbreviations used: NBS, N-Bromosuccinimide; TNM, tetranitromethane; NCS, N-chlorosuccinimide; 
NI S, N-iodosuccinimide; PCMB,p-chloromercuribenzoate. 
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Materials and methods 
 
Cardiotoxin II was purified as described earlier (Achyuthan et al., 1980); Micro- 
coccus lysodeikticus (lyophilised cells) and p-chloromercuribenzoate (PCMB) were 
from Sigma Chemical Co., St. Louis, Missouri, USA; egg-white lysozyme was a gift 
from Societa Prodotti Antibiotici, Milano; NBS from Koch Light, UK; sodium 
borohydride from British Drug House, UK; trinitrobenzene sulphonic acid (TNBS) 
and NCS were gift samples; NIS was recrystallized (dioxane-CCl4) before use and 
had a m.p. 201°C (reported 201°C); dansyl chloride was from Pierce, USA and 
polyamide sheets were from Schleicher and Schuell, Federal Republic of Germany. 
All other chemicals were analytical grade commercial samples. 
The measurements of light absorption were done with a Shimadzu spectrophoto 
meter (Model UV-150-02) or a MSE Spectro-Plus (Model MK1A) or a Coleman 
Junior spectrophotometer (Model 6A). 
 
 
Oxidation of cardiotoxin II with NCS, NBS and NIS 
 
Appropriate amounts (0·325 mg) of cardiotoxin II were dissolved in 3 ml of acetate-
formic acid buffer (0·05 M, pH 4·0), or 0·01 Ν H2SO4 or Tris-HCl buffer 0·1 M, 
pH 8·5. Aliquots (10 µl) of aqueous solutions of NCS or NBS or ethanolic solutions 
of NIS were added to samples and mixed well, so as to ultimately secure levels in 
excess of 1·5 equivalents of oxidant/residue of tyrosine in cardiotoxin II. The increase 
in absorbance at 260 nm was measured after each addition. Necessary corrections 
were made for dilution with appropriate blanks run simultaneously. The additions 
were continued until there was no further increase in absorbance at 260 nm. Based 
on the content of tyrosine residues in cardiotoxin II (Srinivasa et al., 1982) and the 
increase in absorbance at 260 nm, the equivalents of NBS required to oxidize one to 
four tyrosine residues were determined. For further studies unless otherwise men 
tioned, oxidized derivatives were prepared by adding the requisite amount of 
oxidizing agent to known amounts of cardiotoxin II and the derivatives desalted on 
Sephadex G-10 columns, using 0·1 Ν acetic acid for elution. 
Consumption of NBS due to oxidation of formate in acetate-formate buffer was 
followed by iodometry with buffer of strength of 0·005 Μ containing 0·011 Μ NBS. 
At different time intervals, 5 ml of the mixture was withdrawn, excess KI added and 
iodine liberated titrated against 0·01 Ν sodium thiosulphate. 
 
 
Performic acid oxidation 
 
To 0·1 ml of H2O2 (30%) was added 0·9 ml of 98% HCOOH and the same left at 
room temperature (30°C) for 1 h, followed by cooling to 0°C. Cardiotoxin II (1 mg) 
was treated with 1 ml of the above solution at 0°C, for 1 h. The sample was then 
diluted to 10 ml with water and lyophilised. To remove any traces of performic acid 
remaining, the residue was redissolved in 0·5 ml of distilled water and lyophilized 
again. This procedure was repeated twice. 
Reversion of methionine sulphoxide generated, during the oxidation, back to 
methionine in the oxidized protein (0·5 mg) was achieved by treatment with 0·1 ml of 
mercaptoethanol, overnight, at room temperature (26–28°C). The excess of mer-
captoethanol was removed by lyophilisation. 
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Estimation of free amino groups 
 
Free amino groups in cardiotoxin were estimated using the method of Fields (1972). 
The number of free amino groups in the oxidized derivatives was calculated based on 
the molar absorption (EM for TNP group 12,587) of products of reaction with TNBS. 
There are 10 free amino groups in cardiotoxin II (Srinivasa et al., 1982). 
 
 
Determination of disulphide bonds 
 
Estimation of disulphide bonds was carried out by an indirect method. The toxin 
was reduced and the resulting –SH groups were estimated using PCMB as 
described by Boyer (1954). 
The reduction of cardiotoxin II and oxidized derivatives was done using sodium 
borohydride. To appropriate amounts (0·1–0·4 mg) of sample, 0·5 ml of 5% sodium 
borohydride was added and the tubes stoppered and left at 37 ± 1°C for 2·5 h, after 
which excess borohydride was destroyed by the addition of 0·1 ml of 50% acetic 
acid. The last traces of borohydride were eliminated by wetting the sides of the tube 
with 2 ml of 0·33 Μ acetate buffer of pH 4·6, so as to avoid interference during 
estimation of –SH groups using PCMB. After 5 min the required amount 
(1·5-2·0 mol/mol of –SH group) of PCMB was added and mixed well. After 15 min 
at room temperature the increase in absorbance at 255 nm was recorded against appro-
priate blanks. The number of –SH groups was calculated using the known molar 
absorbance (EM255 nm 6200). 
 
 
Dansylation 
 
Dansylation of cardiotoxin and derivatives was carried out according to Hartley 
(1970). 
 
 
Toxicity 
 
The toxicity of the oxidized products (NBS and NCS oxidized) was assayed by 
injecting weights of material corresponding to one to ten LD50 doses of native 
cardiotoxin II, in 0·5 ml of 0·9% saline, intraperitoneally, into Swiss albino mice. The 
animals were kept under observation for a period of 72 h thereafter. 
 
 
Assay of stabilization of bacterial protoplasts: The assay was carried out as descri 
bed earlier (Shashidharan and Ramachandran, 1984). 
 
 
Results 
 
 
Reaction of cardiotoxin II with NCS, NBS and ΝIS 
 
The course of oxidation of cardiotoxin II with increasing concentration of oxidizing 
agents such as NCS, NBS and NIS is shown in figure 1. The increase in absorbance
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Figure 1. Oxidation of cardiotoxin II (0·0158 μmol/ml) under varying conditions with 
increasing concentrations of the reagents: with NBS:(▲), pH 2·0; (▄), pH 4·0; (●), H8·5; 
with NCS: (×), pH 4·0; (?), pH 8·5; with NIS: (O), pH 4·0;(∆), pH 8·5. 
 
 
at 260 nm with increments in amount of reagent used is highest with NBS in acidic 
conditions. Amounts of reagent (NBS) consumed for different degrees of oxidation 
with acetate-formic acid buffer and 0·01 Ν H2 SO4 as media are given in table 1. UV 
spectra of the toxin oxidized with NBS at pH 4·0 are shown in figure 2, while spectra  
 
Table 1. Oxidation of tyrosine residues of cardiotoxin II 
(0·0158 µmol/ml) in acetate-formate bufer and 0·01 Ν H2 SO4. 
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Figured 2. UV spectra of native and foully NBS-oxidized cardiotoxin II (0·0158 µmol/ml). 
(A), native cardiotoxin Π; (Β), cardiotoxin II oxidized in acetate-formate buffer 0·05 M, 
pH4·0; (C), cardiotoxin II oxidized in 0·01 Ν H2 SO4. 
 
 
obtained at pH 8·5 and for oxidations with NCS and NIS in different solvent media 
are not shown. 
The molar absorbance (EM260) of an oxidized tyrosine residue in cardiotoxin was 
found to be 7288 in acetate-formate buffer and 6780 in 0·01 H2 SO4. Reported values 
in the range 10,000-11,000 for dibromodienone spirolactone derivative of tyrosine 
are taken as basis for calculations (Ramachandran and Witkop, 1967). The spectro- 
photometric data would correspond to oxidation of 2·65-2·85 mol of tyrosine/mol of 
toxin. 
 
 
Destruction of NBS by solvent system 
 
Within 20 min after addition of the reagent (NBS) more than 50% of the reagent was 
destroyed in 0·01 M acetate-formate bluffer (pH 4·0) of one-tenth the molarity used in 
routine experiments in which consumption of reagent in oxidation of formate would 
be more rapid. The rate of destruction of NBS in original buffer could not be follo 
wed owing to a nearly instantaneous destruction of reagent. In 0·01 N H2SO4 there 
was no destruction of the reagent. 
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Intactness of free amino groups in cardiotoxin 
Table 2 presents data on number of free amino groups in cardiotoxin II and oxidized 
derivatives. 
 
Table 2. The free amino groups in cardiotoxin II and oxidized cardiotoxin 
II as determined with TNBS. 
 
*Concentration of toxin and the derivatives in the range 0·412–0·429 × 
10-5 Μ were used. 
 
 
Intactness of disulphide bonds 
 
Table 3 provides data on the integrity of disulphide bonds. No cleavage of disulphide 
bonds occurs on oxidation at NBS levels of 3·75 eqs/tyrosine residue (S. No. 2). With 
excess of reagent i.e., 6·25, 9·0 and 16·87 eqs of NBS/tyrosine residue (S. Nos. 3, 4, 5), 
0·8, 1·51 and 2·05 disulphide bonds are, respectively, cleaved oxidatively per mol of 
cardiotoxin. 
 
Table 3. Number of – SH groups generated on reduction of cardiotoxin II and its NBS-oxidized derivatives 
with sodium borohydride. 
 
 
Cleavage of peptide bonds 
 
The release of new terminal amino groups as monitored by dansylation of oxidized 
products showed that there was no detectable new amino terminal residues released 
on oxidation of cardiotoxin II with NBS. Dansylation and hydrolysis did not reveal 
the presence of O-dansyl tyrosine in hydrolyzates of the oxidized derivatives. It was
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however present as expected in the hydrolyzate of dansylated native protein. But 
performic acid-oxidized cardiotoxin on further oxidation with NBS (16·87 eqs/ 
tyrosine residue) contained 3 new amino terminal residues (not identifier), indicating 
peptide bond cleavage under such conditions. 
 
 
Toxicity of oxidized toxin 
 
The derivative obtained on oxidation with 3·75 eqs of NBS/tyrosine residue was 
found to be completely lacking in lethal potency. The derivative was inactive at a 
level corresponding to 10 LD50 doses of native cardiotoxin II . That oxidation of 
cardiotoxin II at a level of 8 eqs NCS/mol of cardiotoxin II did not result in any inacti-
vation of the lethal potency which was revealed by its ability to induce death in mice at 
one LD50 dose. Α sample oxidized with 50 eqs NCS/mol of cardiotoxin was also found 
to cause death in mice but with amounts corresponding to 10 LD50 doses of native 
cardiotoxin II. Performic acid oxidized toxin and the sample in which methionine 
sulphoxides formed on performic acid oxidation were reverted to methionine lacked 
lethality even at such high dose levels. 
 
 
Ability of oxidized derivatives to stabilize bacterial protoplasts from lysis 
 
The lysis of bacterial cells in the presence of various derivatives as followed by 
decrease in turbidity is illustrated in figure 3. The effect of NBS-oxidized derivative 
on bacterial protoplast stabilization and the ability to cause the initial expected 
increase in absorption of the bacterial cell suspension are shown in figure 4. The 
derivatives with one or two tyrosine residues oxidized, and the derivative from 
oxidation with 50 eqs NCS/mol of cardiotoxin were as efficient as native toxin. With 
3 and 4 tyrosine residues of cardiotoxin oxidized, a decrease of 7 and 50% in 
stabilization ability was observed. Performic acid oxidized cardiotoxin II and the 
same derivative in which the methionine was regenerated were not at all active as 
stabilizing agents. On comparison of the ability of the derivatives to enhance 
absorbance of bacterial cell suspensions, it was found that loss of 1 or 2 tyrosine 
residues caused a fall of 36% in this ability, while loss of 3 and 4 tyrosines, caused a 
fall of 50 and 87% respectively. On the other hand the NCS-oxidized sample 
retained 100% of this ability, and the performic acid-oxidized toxin and the sample 
in which the methionine sulphoxide formed on performic acid oxidation was rever- 
ted back to methionine which exhibited a 100% loss of this ability. 
 
 
Discussion 
 
The NBS-oxidation of tyrosine side chains in cardiotoxin II has been examined in 
the present study in the medium 0·05 Μ acetate-formic acid buffer of pH 4·0, a buffer 
credited with the ability to afford protection to protein from secondary oxidations 
(Patchornik et al., 1960). NBS decomposes to CO2, hydrobromic acid and succinimide 
in the above medium instantaneously (Barakat et al., 1955). For reasons which are 
therefore evident, reagent consumption for oxidation of cardiotoxin was relatively 
high (table 1), compared to say in a medium such as acetic acid which is unsuited for
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Figure 3. Time course of bacterial cell lysis inhibition by cardiotoxin II (0·026 µmol/ml) 
and its oxidized derivatives (0··026 µmol/ml): (Ο), lysozyme control; (∆), native cardiotoxin 
II; (⁯), cardiotoxin II with 1 Tyr oxidized; (x), cardiotoxin II with 2 Tyr oxidized; (●), 
cardiotoxin II with 3 Tyr oxidized; (▄), cardiotoxin II with 4 Tyr oxidized; (∆), cardiotoxin 
II oxidized with performic acid, cardiotoxin II oxidized with performic acid and methionine 
sulphoxide reverted to methionine; (– – –), cardiotoxin II oxidized with NCS (see text for 
details). 
 
spectrophotometric observations at the required wavelengths. The solvent 0·01Ν 
H2SO4 in which the reagent is stable did not seem to offer any special advantage as
reagent consumption to effect the same degree of oxidation as in acetate-formic acid 
buffer was found by us to be much higher, for lower levels of oxidation, presumably 
due to low accessibility of tyrosine residues at the lower pH. 
At pH 8·5 NBS and NIS give rise to product spectra with peak absorption at 
310 nm which is attributable to o-dihalogenation of tyrosine residues, but not con 
version to 3,5-dihalogenodienone (λmax 260 nm) at the alkaline pH (spectra not 
shown). At pH 4·0 and 8·5, NCS did not affect the absorption spectrum of cardiotoxin 
II, whereas NIS at pH 4·0 gave rise to a peak of absorption at 290–300 nm, diminu 
tion in the normal phenolate absorption and enhanced absorption at 260 nm and 
lower wavelengths (spectra not shown). Under acidic conditions, only NBS was 
found to be best suited for oxidation of tyrosine residues of cardiotoxin II. 
The lower molar absorption obtained (7288 and 6780 in formate buffer and 0·01 Ν 
H 2 SO4, respectively) for the toxin oxidized with NBS could be due to oxidation of 
some or all of the tyrosines to intermediates other than the dibromodienone lactone 
expected from studies on NBS oxidation of much simpler (small) model substrates
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Figure 4. Effect of oxidation of tyrosine residues in cardiotoxin II with NBS on lysis 
inhibition of M. lysodeikticus cells and increase in initial absorbance of bacterial cell 
suspension. (A), lysis inhibition; (B), increase in absorbance. 
 
 
(peptides). Even ribonuclease which contains 6 tyrosine residues (Hirs et al., 1960) in 
its structure, and therefore not ideally suited for comparison with cardiotoxin, 
cleavage of tyrosyl bonds was achieved by using great excess of oxidant (46 eqs 
NBS/mol of ribonuclease and 30 eqs/mol) with carboxymethyl-ribonuclease (Wilson 
and Cohen, 1963). Based on the spectrophotometric data they showed oxidation of 
only 4·6 tyrosine residues. In the oxidation of cardiotoxin II 2·85 and 2·65 (approx. 3) 
tyrosine residues appeared to have been oxidized in formate buffer and 0·01 Ν 
H2SO4, respectively, based on the extinction expected of dienone (EM  260–10,200). 
Destruction of side chain amino groups of lysozyme by NBS is known
(Ramachandran and Witkop, 1959). This loss in side chain amino groups was also 
noted in cardiotoxin II when treated with excess of NBS (6·25 eqs/tyrosine residue). At 
concentrations of NBS less than this, which is sufficient to cause oxidation equi 
valent to that of two tyrosine residues, there was no loss of amino groups. 
Cleavage of peptide bonds was ruled out in the present oxidative modification 
studies based on the absence of formation of any new reactive N-terminal residues 
by dansylation which offers a sensitive probe. On the contrary, oxidation of per- 
formic acid oxidized cardiotoxin with NBS appears to cause some cleavage of 
peptide bonds. Three extra spots of dansyl amino acids, other than those expected, 
were seen on the chromatogram relative to the control. O-Dansyltyrosine spots were 
not detected on the chromatograms of hydrolyzates of oxidized protein indicating 
that tyrosine residues had undergone modification. 
Present observations on cardiotoxin II revealed that at lower levels of NBS used,
adequate for oxidation of two tyrosine residues, there was no damage to disulphide
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bonds as judged from data on–SH groups generated on reduction with NaBH4 of 
intact –S–S– left untouched by NBS in the modified derivative. However, there was 
oxidative cleavage of disulphide bonds (table 3) with use of larger amounts of NBS 
required to oxidize two more of the tyrosine residues present in the toxin. 
Carlsson and Louw (1978) had selectively modified methionine residues in cardio-
toxin of Naja melanoleuca with NCS (8 eqs/mol of toxin) leading to loss in lethal 
activity. In our studies, toxin treated with 50 eqs of NCS/mol still retained its letha 
lity to mice. Structural differences in the two toxins perhaps account for the diffe- 
rence in susceptibility to loss of biological activity on what is presumed to be oxida 
tion of the two methionine residues in the toxin. On the basis of reactivity 
(Schechter et al., 1975) to NCS, the only two methionines in cardiotoxin II 
may be considered as partly, if not foully, buried. Two methionines (24 and 26) are 
considered invariant in the cardiotoxins (Dufton and Hider, 1983). 
It seems reasonable to conclude that the observed loss of lethality of cardiotoxin
II, on limited NBS oxidation, results from the oxidation of a single tyrosine residue, 
whose location in the structure will remain to be ascertained. 
The ability of the toxin to confer stability to bacterial protoplasts was not affected
when oxidized with lower amounts of NBS. However, a fully oxidized derivative 
exhibited a retention of only about 50% of such activity. Loss of the remaining 50% 
of the activity occurs only when the two left-over tyrosine residues, 3 amino groups 
and two disulphide bonds are oxidatively modified. Marked differences that were 
observed in the ability of derivatives in bringing about initial increase in absorbance 
of bacterial cell suspensions may be due to involvement of different structural 
elements in the toxin in the two functions. 
Three-dimensional structural integrity associated with disulphide bonds seems to
be important for the protoplast stabilization activity of the toxin. Performic acid 
oxidized toxin is thus inactive, even though all 10 amino groups remain intact. The 
basic property of the molecule as such seems inadequate, although with compounds 
such as spermine and related polyamines, which stabilize protoplasts under hypo- 
tonic conditions, this property has been invoked to account for the phenomenon 
(Tabor, 1962). With fully NBS-oxidized cardiotoxin, which still retains two intact 
disulphide bonds and 7 of the original 10 amino groups, 50% retention of the ability 
of the native toxin to protect protoplasts is observed. 
Earlier studies using tetranitromethane (Keung et al., 1975; Carlsson, 1980) did not
fully establish the importance of tyrosine residues in the biological activity of the 
cardiotoxins studied, since modified derivatives retained atleast partial biological 
activity, such as lethal potency, haemolytic activity and cytolytic activity. In contrast, 
the use of the NBS in oxidation of the tyrosine residues in cardiotoxin of the Indian 
cobra reveals the importance of a tyrosine residue in relation to lethal activity. The 
tyrosine residue that is involved could be the equivalent of the invariant residue (Tyr 
22) which had been noted in cardiotoxins from species other than Naja naja (Joubert, 
1976; Ryden et al., 1973). This tyrosine residue, however, seems unimportant for 
protecting bacterial protoplast membranes against lysis under hypotonic conditions. 
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